TP53-associated early breast cancer: new observations from a large cohort.

Autor: Sandoval RL; Medical Oncology Center, Hospital Sírio-Libanês, Brasília, DF, Brazil.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Bottosso M; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.; Medical Oncology Department, Gustave Roussy Cancer Campus, INERM U981, Université Paris Saclay, France., Tianyu L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Polidorio N; Breast Surgery Department, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA, USA., Verret B; Medical Oncology Department, Gustave Roussy Cancer Campus, INERM U981, Université Paris Saclay, France., Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Cahill S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Achatz MI; Medical Oncology Center, Hospital Sírio-Libanês, São Paulo, SP, Brazil., Caron O; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France., Imbert-Bouteille M; Oncology Department, Institut of Cancer of Montpellier, Montpellier, France., Noguès C; Cancer Risk Management Department, Clinical Oncogenetics, Institut Paoli-Calmettes, Marseille, France.; Aix Marseille Université, INSERM, IRD, SESSTIM, Marseille, France., Mawell KN; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Fortuno C; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Spurdle AB; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Tayob N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Andre F; Medical Oncology Department, Gustave Roussy Cancer Campus, INERM U981, Université Paris Saclay, France., Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Aug 01; Vol. 116 (8), pp. 1246-1254.